CPL is serialisation-ready, in compliance with the Drug Quality Security Act (DQSA).

Though compliance was not mandatory until November 2017, the company was ahead of the curve to ensure its products are traceable according to US Food and Drug Administration (FDA) standards.

I addition, the company has invested in a serialisation strategy for both software and hardware systems to support its partners’ serialisation requirements with an ongoing strategy for aggregation as new traceability laws take effect.